Speaker illustration

Doctor Josip Andjelo Borovac

University Hospital Centre Split, Split (Croatia)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Josip A. Borovac (MD, PhD, FESC, FHFA) is a Faculty member at the Department of Pathophysiology, University of Split School of Medicine, and an interventional cardiology fellow at the Cardiovascular Diseases Department, University Hospital of Split, Croatia. He represents Croatia in the HFA Young Committee, serves as a member of HFA’s Committee on Devices and is an ex-Nucleolus member of the ESC Working Group on Thrombosis Young Researchers. He published a vast amount of scientific publications in areas of his clinical interest including interventional cardiology, heart failure, ACS, and PCI. He currently serves on the Editorial boards of several academic journals such as BMC Cardiovascular Disorders, Cardiac Failure Review, Medicine, European Heart Journal Case Reports, and Cardiac Catheterization and Interventions (CCI). He is an active and contributing member in European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Heart Failure Association (HFA).

Symptom of dyspnea among all-comers admitted for acute myocardial infarction is an independent and powerful predictor of poor in-hospital outcomes

Event: Heart Failure 2023

Topic: Clinical

Session: Coronary artery disease / Chronic coronary syndromes

Thumbnail

Left atrial strain is improved with addition vs. no addition of SGLT2 inhibitor to background heart failure pharmacotherapy among patients with HFrEF: a prospective cohort study with 3-month follow-up

Event: Heart Failure 2023

Topic: Imaging

Session: Chronic heart failure - imaging 2

Thumbnail

The association of CABG vs. PCI on echocardiographic indices of global longitudinal strain and myocardial work in patients with HFrEF and ischemic cardiomyopathy: a pilot study

Event: Heart Failure 2022

Topic: Imaging

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Thumbnail

Patients with non-ischemic dilated cardiomyopathy and AF exhibit worse global longitudinal strain and reduced work index and constructive work of the myocardium compared to those without AF

Event: Heart Failure 2022

Topic: Heart Failure in Atrial Fibrillation

Session: Heart Failure ePosters - focus on Arrhythmias and device

Thumbnail

Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiarrhythmic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on ischemic outcomes among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 106,405 patients from 12 studies

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on major bleeding among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 41,548 patients from 11 studies

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients

Event: Heart Failure 2021

Topic: Angiotensin-Renin-Bradykinin System

Session: ePoster session

Thumbnail

Use of SGLT2 inhibitors and the incidence of urinary tract infections in patients with heart failure: a pooled analysis of four trials including 26,838 patients

Event: Heart Failure 2021

Topic: Antidiabetic Pharmacotherapy

Session: ePoster session

Thumbnail

The predictive value of CHA2DS2-VASc score on adverse in-hospital outcomes among patients with the acute coronary syndrome and atrial fibrillation who undergo PCI

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, Prognosis, Outcome in Acute Coronary Syndromes – New Insights

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb